| Title |
|
|
|
Diarylquinolines, synthesis pathways and quantitative structure-activity relationship studies leading to the discovery of TMC207
| |
| Author |
|
|
|
| |
| Abstract |
|
|
|
| The emergence of multidrug-resistant strains of Mycobacterium tuberculosis and resistance to current anti-TB drugs call for the discovery and development of new effective anti-TB drugs. TMC207 is the lead candidate of a novel class of antimycobacterial agents, the diarylquinolines, which specifically inhibit mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis. This article covers both synthesis pathways as well as qualitative and quantitative analyses of the structureactivity relationships of the diarylquinoline series on Mycobacterium smegmatis activity. | | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Future medicinal chemistry | |
| Publication |
|
|
|
2011
| |
| Volume/pages |
|
|
|
3:11(2011), p. 1345-1360
| |
| ISI |
|
|
|
000294544900009
| |
| Full text (Publisher's DOI) |
|
|
| | |
|